RHENMAN & PARTNERS ASSET MANAGEMENT AB Edwards Lifesciences Corporation Transaction History

RHENMAN & PARTNERS ASSET MANAGEMENT AB portfolio value:

$9.05M
portfolio value

RHENMAN & PARTNERS ASSET MANAGEMENT AB quarter portfolio value change:

-13.10%
quarter

Edwards Lifesciences Corporation 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +177.78% 80K shares 4.77M $82.63 125K
Q2 2022 share Decrease -30.77% -20K shares -3.37M $95.09 45K
Q1 2022 share Decrease -35.00% -35K shares -5.41M $117.72 65K
Q4 2021 share Decrease -4.76% -5K shares 1.18M $130.68 100K
Q3 2021 share Decrease -4.55% -5K shares 494K $113.21 105K
Q2 2021 share 0.00% 0 shares 2.19M $103.57 110K
Q1 2021 share Decrease -12.00% -15K shares -2.20M $83.64 110K
Q4 2020 share Increase +4.17% 5K shares 1.82M $91.23 125K
Q3 2020 share 0.00% 0 shares 1.28M $79.82 120K
Q2 2020 share Decrease -29.82% -51K shares -2.45M $69.11 120K
Q1 2020 share Increase +50.00% 57K shares 1.88M $62.87 171K
Q4 2019 share Increase +3.87% 4.24K shares 820K $77.76 114K
Q3 2019 share Increase +15.83% 15K shares 2.21M $73.3 109.75K
Q2 2019 share Increase +18.81% 15K shares 748K $61.58 94.75K
Q1 2019 share Decrease -60.07% -120K shares -5.11M $63.78 79.75K
Q4 2018 share Decrease -31.06% -90K shares -6.61M $51.06 199.75K
Q3 2018 share Increase +41.28% 84.66K shares 6.86M $58.03 289.75K
Q2 2018 share Decrease -17.99% -45K shares -1.67M $48.52 205.09K
Q1 2018 share Increase +13.63% 30K shares 3.36M $46.51 250.09K
Q4 2017 share Decrease -8.29% -19.90K shares -476K $37.57 220.09K
Q3 2017 share Increase +142.42% 141K shares 4.84M $36.44 240K
Q2 2017 share Decrease -45.00% -81K shares -1.74M $39.41 99K
Q1 2017 share Decrease -14.29% -30K shares -915K $31.36 180K
Q4 2016 share Increase +27.27% 45K shares -71.8K $31.23 210K
Q3 2016 share Decrease -21.43% -45K shares -350.2K $40.19 165K
Q2 2016 share Increase +27.27% 45K shares 2.12M $33.24 210K
Q1 2016 share Increase +12.24% 18K shares 982K $29.4 165K